Latest News and Press Releases

ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

The FDA is making AI part of the R&D core infrastructure and companies like Totaligent (OTCID: TGNT) are building the “picks-and-shovels” layer of biotech

ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law

ADMA Biologics Securities Class Action Investigation Ongoing – Investors with Losses after 29% Stock Drop Notified to Contact BFA Law

Vista, CA, April 22, 2026 (GLOBE NEWSWIRE) -- Mindera Health, a leader in precision medicine for dermatological conditions, today announced it has received approval from the New York State...

BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation

ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law

ADMA Biologics (NASDAQ:ADMA) Securities Fraud Investigation Over Channel Stuffing Claims is Ongoing – Contact BFA Law if You Lost Money

Totaligent (OTCID:TGNT) executed a Definitive Agreement with for the strategic acqui-hire of the Aetherium Medical platform and team.